Runben Biotechnology Co Ltd
SSE:603193
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
|
Runben Biotechnology Co Ltd
SSE:603193
|
9.1B CNY |
Loading...
|
|
| US |
|
Kenvue Inc
NYSE:KVUE
|
33.9B USD |
Loading...
|
|
| KR |
A
|
APR Co Ltd
KRX:278470
|
12.3T KRW |
Loading...
|
|
| BR |
|
Natura &Co Holding SA
OTC:NTCOY
|
7.7B USD |
Loading...
|
|
| KY |
H
|
Herbalife Ltd
XMUN:HOO
|
4.4B EUR |
Loading...
|
|
| CN |
M
|
Mao Geping Cosmetics Co Ltd
HKEX:1318
|
37.9B HKD |
Loading...
|
|
| KR |
D
|
d'Alba Global Co Ltd
KRX:483650
|
1.8T KRW |
Loading...
|
|
| IN |
H
|
Honasa Consumer Ltd
NSE:HONASA
|
86.7B INR |
Loading...
|
|
| ID |
|
Industri Jamu dan Farmasi Sido Muncul Tbk PT
IDX:SIDO
|
15T IDR |
Loading...
|
|
| CN |
D
|
Dencare Chongqing Oral Care Co Ltd
SZSE:001328
|
5.9B CNY |
Loading...
|
|
| CN |
|
Hangzhou Minsheng Healthcare Co Ltd
SZSE:301507
|
5.3B CNY |
Loading...
|
Market Distribution
| Min | -416 945.9% |
| 30th Percentile | -1.5% |
| Median | 3.5% |
| 70th Percentile | 8.9% |
| Max | 17 382.1% |
Other Profitability Ratios
Runben Biotechnology Co Ltd
Glance View
Runben Biotechnology Co., Ltd. engages in the research and development, manufacture, and sale of mosquito repellent, baby care products, and personal care products. The company is headquartered in Guangzhou, Guangdong and currently employs 917 full-time employees. The company went IPO on 2023-10-17. The firm's main products can be divided into three sectors: mosquito repellent products, baby care products and essential oil products. The firm's principal products include electric mosquito repellent liquid, DEET mosquito repellent liquid, lipstick, face cream, facial cleanser, skin care cream and others. The firm mainly provides products to consumers through Internet sales models such as online direct sales, online platform distribution, and online platform agency sales. The firm mainly conducts its businesses in the domestic market.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Runben Biotechnology Co Ltd is 20.1%, which is below its 3-year median of 20.5%.
Over the last 3 months, Runben Biotechnology Co Ltd’s Net Margin has decreased from 20.9% to 20.1%. During this period, it reached a low of 20.1% on Sep 30, 2025 and a high of 20.9% on Jun 30, 2025.
